FDA Inspection 1029680 — Southern Blood Services Inc

Southern Blood Services Inc — FEI 3002597075

The FDA completed an inspection of Southern Blood Services Inc on October 17, 2017 in Nashville, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 17, 2017
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Nashville, TN (United States)